Retinal Diseases Clinical Trial
Official title:
Long-Working Distance OCT System With Fixation Alignment for Pediatric Imaging
Young children age 6 month to 6 years are often not able to cooperate for advanced OCT eye imaging. The purpose of this study is to investigate the use of a novel long-working distance swept source (SS) optical coherence tomography imaging system with fixation alignment for use first in young adults, older children, and then young children ages 6 months to 6 years. The investigator's future goal is to obtain important retinal and optic nerve information from OCT in clinic in these young children.
The overall objective of this study is to examine the utility of a long-working distance high speed SSOCT system along with technology to identify and use movies, etc. to aid with fixation. This study would be the first testing of such a system, first in adults and then moving to older children who could provide feedback, and then to young children. This imaging data will be compared to other clinical tests and images collected during regular health care and eye examinations. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04968756 -
Evaluating the Safety of the SPECTRALIS CENTAURUS Device
|
N/A | |
| Recruiting |
NCT01521065 -
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
|
Phase 2 | |
| Completed |
NCT00437593 -
UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue
|
N/A | |
| Completed |
NCT04919473 -
Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
| Completed |
NCT01205035 -
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
|
Phase 2 | |
| Terminated |
NCT01225146 -
Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
|
Phase 1 | |
| Completed |
NCT00812760 -
Effect of Levodopa on Human Multifocal Electroretinogram
|
Phase 4 | |
| Active, not recruiting |
NCT06071546 -
Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology
|
N/A | |
| Completed |
NCT02946879 -
Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)
|
||
| Completed |
NCT01016873 -
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
|
Phase 2 | |
| Recruiting |
NCT04592068 -
AI Classifies Multi-Retinal Diseases
|
||
| Completed |
NCT01746563 -
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT01399515 -
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
|
Phase 2 | |
| Terminated |
NCT02348359 -
X-82 to Treat Age-related Macular Degeneration
|
Phase 2 | |
| Completed |
NCT03954626 -
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
|
Phase 3 | |
| Completed |
NCT01790958 -
Microcurrent Stimulation to Treat Macular Degeneration
|
N/A | |
| Recruiting |
NCT05283941 -
Pistachios and Neural Macular Pigment
|
N/A | |
| Completed |
NCT04678375 -
Artificial Intelligence for Detecting Retinal Diseases
|
||
| Completed |
NCT04902170 -
Long-shaft Vitrectomy Probe in Highly Myopic Eyes
|
N/A | |
| Completed |
NCT02543229 -
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
|
Phase 1 |